Navigation Links
Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
Date:2/21/2012

SAN DIEGO, Feb. 21, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Citi 2012 Global Health Care Conference in New York.   

The live presentation takes place on Wednesday, February 29 at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
2. Neurocrine Biosciences Reports Third Quarter 2011 Results
3. Neurocrine Biosciences Reports Second Quarter 2011 Results
4. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
5. Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
6. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
7. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
8. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
9. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
10. Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix
11. Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... YORK , Dec. 23, 2014  NeuroLifeSciences announced ... mazindol in children with attention deficit/hyperactivity disorder published in ... . The paper, titled "Pilot Phase ... disorder" ( Konofal et al, Drug Des ... ) shows that mazindol might be an effective, ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
(Date:12/22/2014)... N.C. , Dec. 22, 2014  Alternative ... announced that it has signed a letter of ... that has developed and patented a nanotechnology-based development ... diagnostics products that enable rapid on-site collection and ... use/abuse and health issues in an immediate, non-invasive ...
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... D Garteiz, TexMS Analytical Services, Houston, TX , ... A Varian 1200L LC/MS/MS system was used for the quantitation of the ... urinary tract using a urethra suppository mode of administration. , ... major health problem in the U.S. and will continue to grow with ...
... Activation of B cells through the B cell receptor ... pathway although, in many cases, different members of the same kinase ... family and have similar sequences and structures. Crosslinking of the CD3 ... are Src family tyrosine kinases 1,2 . These kinases phosphorylate ITAM ...
... , ... The understanding of the cellular signaling processes leading to programmed ... autoimmune diseases such as rheumatoid arthritis or Parkinsons and Alzheimers disease. ... premature apoptosis in the affected tissue. At the same time, damaged ...
Cached Biology Technology:Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System 2Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System 3Research Tools for Analysis of ZAP-70 2Research Tools for Analysis of ZAP-70 3Caspase-3 Activation - An Indicator of Apoptosis in Image-Based Assays 2Caspase-3 Activation - An Indicator of Apoptosis in Image-Based Assays 3Caspase-3 Activation - An Indicator of Apoptosis in Image-Based Assays 4Caspase-3 Activation - An Indicator of Apoptosis in Image-Based Assays 5
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... to be genetically predetermined and evolutionarily innate, such as ... These qualities drive the nature versus nurture debate and ... why? Psychologists Agneta Herlitz and Jenny Rehnman ... of human predisposition: Does ones sex influence his or ...
... have been used for decades to take pictures of ... Energys (DOE) Argonne National Laboratory and their collaborators have ... of ultra-small structures buried in nanoparticles and nanomaterials, and ... Argonne scientists along with scientists from the University ...
... center of some of the nation,s most pressing challenges, ... change. To provide a critical overview of America,s energy ... leading energy experts from the government, research institutions, and ... study under way called "America,s Energy Future: Technology Opportunities, ...
Cached Biology News:Total, genetically-based recall 2Lensless camera uses X-rays to view nanoscale materials and biological specimens 2Lensless camera uses X-rays to view nanoscale materials and biological specimens 3NAS to hold 2-day summit on energy issues 2
... Fully adjustable mixing angle, Variable speed, Digital ... a number of different sized tubes, Spillage ... cultures, keeping biological samples in suspension and ... be used in incubators up to 60C ...
...
... real-time PCR detection system uses a fixed ... nm) and two photomultiplier tubes for 2-color ... 2 system is built on an DNA ... gradient feature. This item includes the thermal ...
... is used to screen blots of mini format ... screen up to 40 different antibodies or sera ... The apparatus includes a base plate, 2 separate, ... 8 x 7 cm membranes, and gaskets and ...
Biology Products: